Minimally invasive coronary artery bypass grafting for myocardial muscle bridging

J W Pratt1, R E Michler, J Pala

  • 1Division of Cardiothoracic Surgery and Division of Cardiology, The Ohio State University, Columbus 43210-1228, USA.

Insights

Myocardial bridging, a congenital heart defect, can cause serious issues. Minimally invasive bypass surgery offers a viable alternative for patients with severe symptoms, avoiding traditional open-heart procedures.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Surgical Innovation

Background:

  • Myocardial bridging is a congenital anomaly affecting the left anterior descending coronary artery (LAD).
  • It is linked to significant cardiovascular events, including ischemia, infarction, arrhythmias, and sudden cardiac death.
  • Medical management often proves insufficient for symptomatic cases.

Observation:

  • Two cases of symptomatic myocardial bridging, unresponsive to medical therapy, were successfully treated.
  • The treatment involved minimally invasive coronary artery bypass grafting (CABG).
  • Crucially, the procedure was performed without cardiopulmonary bypass.

Findings:

  • Minimally invasive CABG without cardiopulmonary bypass effectively managed symptomatic myocardial bridging.
  • This approach provided a successful alternative to other interventions.
  • Patient outcomes suggest the efficacy of this surgical technique.

Implications:

  • Minimally invasive CABG is a suitable alternative to stent placement, muscle division, or traditional CABG with cardiopulmonary bypass.
  • This technique offers a less invasive option for symptomatic myocardial bridging.
  • It expands treatment possibilities for this congenital anomaly.

Related Concept Videos